Compounds of the formula:
are useful in treating disease conditions mediated by TNF-&agr;, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.
The invention relates to CB2 agonists of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
本发明涉及公式(I)中R1至R4如描述和权利要求所定义的CB2激动剂。公式(I)化合物可用作药物。
NOVEL PYRAZINE DERIVATIVES AS CB2 RECEPTOR AGONISTS
申请人:HOFFMANN-LA ROCHE INC.
公开号:US20150299220A1
公开(公告)日:2015-10-22
The invention relates to a compound of formula (I) wherein R
1
to R
4
are defined as in the description and in the claims. The compound of formula (I) is a CB2 receptor agonist for use in the treatment of several disorders, such as pain, atherosclerosis and glaucoma.
The invention relates to CB2 agonists of formula (I) wherein R
1
to R
4
are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.